Operating Expenses Cambio Fecha
Agios Pharmaceuticals USD 113.38M 5.08M 2023-12
Alnylam Pharmaceuticals USD 556.12M 19.46M 2023-12
Amgen USD 6.93B 2.11B 2023-12
Biogen USD 2.03B 344.1M 2023-12
BioMarin Pharmaceutical USD 631.99M 76.32M 2023-12
Bluebird Bio USD 97.12M 4.93M 2023-09
Daiichi Sankyo JPY 324.48B 17.68B 2023-09
Esperion Therapeutics USD 61.5M 1.34M 2023-09
Exelixis USD 489.5M 97.5M 2023-09
Gilead Sciences USD 5.5B 1.08B 2023-12
Incyte USD 826.07M 121.75M 2023-12
Moderna USD 2.8B 1.04B 2023-12
Pfizer USD 20.8B 4.62B 2023-12
PTC Therapeutics USD 438.79M 124.05M 2023-12
Regeneron Pharmaceuticals USD 2.46B 209.7M 2023-12
Roche Holding CHF 20.02B 5.04B 2023-06
Sarepta Therapeutics USD 380.16M 87.4M 2023-09
Takeda JPY 1.09T 202.38B 2023-09
TG Therapeutics USD 56.46M 5.42M 2023-12
Ultragenyx Pharmaceutical USD 249.44M 6.29M 2023-12
Vanda Pharmaceuticals USD 48.92M 11.57M 2023-06
Vertex Pharmaceuticals USD 1.45B 21.4M 2023-09



Puma Biotechnology Los Gastos De Explotación - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2024.